Literature DB >> 12231274

Combined clozapine and valproic acid treatment-induced agranulocytosis.

R Madeb, S Hirschmann, R Kurs, A Turkie, I Modai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12231274     DOI： 10.1016/s0924-9338(02)00659-4

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN： 0924-9338            Impact factor:   5.361


× No keyword cloud information.
  5 in total

Review 1.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Seizure associated with clozapine: incidence, etiology, and management.

Authors:  Andrew M Williams; Susie H Park
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

3.  Never Say Never: Successful Clozapine Rechallenge After Multiple Episodes of Neutropenia.

Authors:  Michael Shuman; Lori Moss; Adam Dilich
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-01-25

4.  Neutropenia and Leukopenia After Cross Taper From Quetiapine to Divalproex for the Treatment of Borderline Personality Disorder.

Authors:  Caroline Richmond; Stephanie Coveart
Journal:  Fed Pract       Date:  2022-04-11

5.  Clozapine-associated neutropenia following augmentation with sodium valproate.

Authors:  Michelle Iris Jakobsen; H Grønborg; H V Hansen; A Fink-Jensen
Journal:  SAGE Open Med Case Rep       Date:  2021-05-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.